According to a study published in the New England Journal of Medicine, short-term use of estrogen plus progestin significantly decreased the risk of colorectal cancer among postmenopausal women; however, for unknown reasons, the colorectal cancers that did develop in the hormone-treated group were diagnosed at a more advanced stage.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Estrogen/progestin linked with more severe colorectal cancer

Newsletter